clopenthixol has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastiampillai, T; Cheng, R; Dhillon, R; Fonseka, HT; Tibrewal, P | 1 |
| Desautels, R; Rej, S | 1 |
2 other study(ies) available for clopenthixol and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Use of zuclopenthixol in the treatment of aggression in Huntington's disease.
Topics: Adult; Aggression; Antipsychotic Agents; Clopenthixol; Humans; Huntington Disease; Male; Treatment Outcome | 2017 |
Experience with intramuscular zuclopenthixol and medroxyprogesterone acetate in the treatment of agitation and aggression in Huntington's disease.
Topics: Aggression; Antineoplastic Agents, Hormonal; Antipsychotic Agents; Clopenthixol; Humans; Huntington Disease; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Psychomotor Agitation | 2013 |